DSP Clinical Research

While others are getting up to speed, DSP is getting results. DSP Clinical Research is an award-winning, comprehensive CRO that delivers three distinct advantages — dedicated experts, straightforward pricing, and a perfect partnership. With a track record for getting drugs to market faster, DSP has managed over 400 clinical trials in Phases I through IV across various therapeutic areas and has filed 26 regulatory submissions including NDAs, 510(k)s and PMAs. Whether we are managing the entire study from start to finish or providing individual services, DSP’s global capabilities drive top-tier success for pharmaceutical, biotech and device companies through unmatched experience, passionate leadership, aggressive strategies, and operational excellence. We provide on-demand management and monitoring services that instantly scale to fit the size, complexity, and speed of your research study. Our extensive expertise covers a wide range of therapeutic areas that include women’s health, endocrinology, infertility, urology, gastrointestinal, pain and central nervous system studies. DSP takes a proactive, meticulous approach to customer studies and services. We understand customer needs and won’t settle for anything less than precision and accuracy for your clinical trial. At DSP, we provide an effortless contracting process with fixed pricing, integrated budgeting, and no long-term contracts to simplify service delivery and minimize overhead. We identify and resolve potential study issues early and strategically allocate resources to ensure project completion on time and on budget. Our proven internal SOPs and QA metrics ensure that quality systems are in place and rigorously followed during every customer’s clinical study. As a result of sustained company growth, we have ranked prominently on the Inc. 500/5000 list multiple times. That’s a difference you can see. Distinctly DSP.

网站

https://www.dspclinical.com

DSP Clinical Research的外部链接

所属行业

专业服务

规模

11-50 人

总部

Montclair，New Jersey

类型

私人持股

创立

2003

领域

Women's Health、Pediatrics、Pain、Urology、Reproductive Endocrinology、Oncology、Central Nervous System、Cardiovascular、Devices、Infertility、Endocrinology和Phase I